SEC Form 4 · accession 0001093557-16-000758

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CTO

Period of report

Dec 9, 2016

Accepted (ET)

Dec 13, 2016 · 4:21 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Dec 9, 2016	M	2,637	$7.79	A	74,971	D
Common Stock^F1,F2	Dec 9, 2016	S	2,637	$64.8079	D	72,334	D
Common Stock	Dec 9, 2016	M	3,438	$7.25	A	75,772	D
Common Stock^F1,F2	Dec 9, 2016	S	3,438	$64.8079	D	72,334	D
Common Stock	Dec 9, 2016	M	3,925	$7.79	A	76,259	D
Common Stock^F1,F2	Dec 9, 2016	S	3,925	$64.8079	D	72,334	D
Common Stock^F3	holding	—	—		—	3,499	I	by Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Incentive Stock Option (right to buy)	$7.25	Dec 9, 2016	M	3,438	D	Mar 9, 2008	Mar 9, 2017	Common Stock	3,438	0	D
Incentive Stock Option (right to buy)	$7.79	Dec 9, 2016	M	2,637	D	Aug 2, 2008	Aug 2, 2017	Common Stock	2,637	7,000	D
Non-Qualified Stock Option (right to buy)	$7.79	Dec 9, 2016	M	3,925	D	Aug 2, 2008	Aug 2, 2017	Common Stock	3,925	0	D

F1On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2Included in this number are 72,334 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 22,500 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 11,834 of which were granted on March 8, 2014 and shall vest through March 8, 2017.
F3Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.